Brian Rosenberger
VP, Commercial, Zynerba Pharmaceuticals.
Companies
- Zynerba PharmaceuticalsVP, Commercial Jan 25, 2017 to Oct 11, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Zynerba Pharmaceuticals ZYNE0 shares2Oct 10, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 10, 2023U 300,000 shares of Zynerba Pharmaceuticals2
- Oct 10, 2023Granted 120,000 shares of Zynerba Pharmaceuticals2
- Oct 10, 2023U 69,559 shares of Zynerba Pharmaceuticals2
- Sep 13, 2023Sold 6,411 shares at $1.33 of Zynerba Pharmaceuticals3
- Sep 12, 2023Granted 22,200 shares of Zynerba Pharmaceuticals3
- Feb 8, 2023Shares withheld for tax 5,145 shares at $0.60 of Zynerba Pharmaceuticals4
- Feb 7, 2023Granted 14,926 shares of Zynerba Pharmaceuticals4
- Feb 1, 2023Shares withheld for tax 4,809 shares at $0.60 of Zynerba Pharmaceuticals5
- Jan 31, 2023Granted 13,950 shares of Zynerba Pharmaceuticals5
- Jan 24, 2023Granted 120,000 shares of Zynerba Pharmaceuticals6
- Jan 23, 2023Sold 12,663 shares at $0.60 of Zynerba Pharmaceuticals6
- Jul 19, 2022Sold 4,289 shares at $1.10 of Zynerba Pharmaceuticals7
- Jul 18, 2022Granted 14,800 shares of Zynerba Pharmaceuticals7
- Jan 26, 2022Granted 60,000 shares of Zynerba Pharmaceuticals8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Sep 14, 2023
- 4SEC EDGARForm 4 filed Feb 9, 2023
- 5SEC EDGARForm 4 filed Feb 2, 2023
- 6SEC EDGARForm 4 filed Jan 25, 2023
- 7SEC EDGARForm 4 filed Jul 20, 2022
- 8SEC EDGARForm 4 filed Jan 28, 2022